BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9289806)

  • 21. Medical management of specific clinical presentations.
    Bitton A; Peppercorn MA
    Gastroenterol Clin North Am; 1995 Sep; 24(3):541-58. PubMed ID: 8809235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment strategies for inflammatory bowel disease].
    Lémann M; Allez M
    Rev Prat; 2005 May; 55(9):984-92. PubMed ID: 16052969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacologic therapy of Crohn's disease and ulcerative colitis].
    Banai J
    Orv Hetil; 2000 May; 141(22):1171-7. PubMed ID: 10853345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current treatment modalities in active Crohn's disease.
    Biancone L; Pallone F
    Ital J Gastroenterol Hepatol; 1999; 31(6):508-14. PubMed ID: 10575571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
    Dölle W; Daiss W
    Verh Dtsch Ges Inn Med; 1988; 94():184-91. PubMed ID: 2905099
    [No Abstract]   [Full Text] [Related]  

  • 31. Current dilemmas in the management of inflammatory bowel disease.
    Rutgeerts P
    Eur J Surg Suppl; 2002; (587):58-61. PubMed ID: 16144202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
    Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
    Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug treatment of Crohn's disease].
    van Deventer SJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
    Sands BE
    Gut; 2006 Apr; 55(4):437-41. PubMed ID: 16531519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inflammatory bowel diseases].
    Kruis W
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
    Fiocchi C
    Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V; Munkholm P
    Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease.
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1121-7. PubMed ID: 10524641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.